Mirion Technologies' consensus price target has been revised upward, primarily reflecting a notable improvement in net profit margin and a substantial decline in future P/E, which together indicate stronger profitability and a more attractive valuation.
What's in the News
- Mirion Technologies updated 2025 earnings guidance with higher expected revenue growth of 7.0%-9.0% (previously 5.0%-7.0%), factoring in FX and acquisition tailwinds; organic revenue growth revised to 5.0%-7.0% (previously 5.5%-7.5%).
- Launched the Vital Platform, a unified software suite for nuclear power sites to enhance operational efficiency, worker safety, regulatory compliance, cost reduction, data integration, and security; initial application, Vital Supervision, focuses on real-time radiological instrument monitoring.
- Announced a strategic partnership with Westinghouse Electric to upgrade analog neutron flux monitoring systems in nuclear reactors to digital, using Mirion’s proTK product line, providing drop-in replacements for legacy systems and minimizing disruption.
- Introduced multiple new products at the SNMMI Annual Meeting, including the Graves Phantom for dosimetry calibration, InstadoseVUE Beta wireless dosimeter, updated ec2 software suite, enhanced Apex-Guard software, and new mobile radiation monitoring devices.
- Dropped as a constituent from several Russell Value and Small/Mid Cap Indexes, including the Russell 3000 Value, 2000 Value, 2500 Value, and related benchmarks.
Valuation Changes
Summary of Valuation Changes for Mirion Technologies
- The Consensus Analyst Price Target has risen slightly from $22.20 to $22.83.
- The Net Profit Margin for Mirion Technologies has significantly risen from 6.14% to 9.45%.
- The Future P/E for Mirion Technologies has significantly fallen from 92.73x to 60.05x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.